West Nile virus vaccine - MacroGenics
Alternative Names: WNV vaccineLatest Information Update: 21 Jul 2009
Price :
$50 *
At a glance
- Originator National Institutes of Health (USA)
- Developer MacroGenics; National Institutes of Health (USA)
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued West Nile virus infections
Most Recent Events
- 16 Aug 2005 West Nile Virus vaccine is available for licensing (http://www.macrogenics.com)
- 21 Feb 2005 Phase-I/II clinical trials in West Nile virus infections prevention in USA (unspecified route)
- 20 Oct 2004 Preclinical trials in West Nile virus infections prevention in USA (unspecified route)